Bayberry

What is Bayberry?

Bayberry is the root bark of Myrica cerifera L., an evergreen shrub of the family Myricaceae that grows from New Jersey south to Florida, Texas, the Caribbean and Central America. Plants of the World Online accepts Myrica cerifera L. as the current name and lists Morella cerifera (L.) Small as a homotypic synonym, which is why two different binomials appear on bottles of the same product. In the NIH Dietary Supplement Label Database, checked in August 2026, 14 bayberry labels print the genus as Myrica and 5 print it as Morella. Both are the same plant. The confusion is a taxonomy argument, not a sourcing difference.

Three other plants answer to overlapping names, and only one of them is even a relative. Myrica pensylvanica Mirb., northern bayberry, also placed as Morella pensylvanica (Mirb.) Kartesz, is the deciduous cold-hardy species that runs from Newfoundland down to North Carolina. It is the classic bayberry-candle shrub of New England, it is a genuine congener, and it has almost no pharmacological literature at all: 43 Europe PMC records against 230 for M. cerifera. Do not treat data from one as data from the other. Myrica rubra (Lour.) Siebold and Zucc., Chinese bayberry or yangmei, is a farmed fruit tree with an entirely separate body of research, covered under Food Sources below. And bay leaf, Laurus nobilis L., is not a bayberry in any sense. It sits in the family Lauraceae and the order Laurales, while every true bayberry sits in Myricaceae and the order Fagales, alongside oaks and birches. The shared syllable is an accident of English.

A fourth wrinkle is genus-level. Before 2002 the genus Myrica held roughly 97 species. Macdonald's argument for splitting it into Myrica and Morella was accepted that year, and a large share of species moved. That is why literature published before about 2005 files compounds under names that no longer match current floras, and why a supplier can print either binomial without being wrong.

Common Names

• Southern bayberry, wax myrtle, southern wax myrtle

• Candleberry, tallow shrub, waxberry

• Bayberry bark, bayberry root bark, Myrica bark

• Morella cerifera, the name used by several US floras and by Herb Pharm on its tincture

Primary Active Compounds

• Myricitrin, the 3-O-rhamnoside of myricetin, CAS 17912-87-7, the main flavonoid glycoside of the bark

• Myricadiol, a taraxerane triterpene diol, UNII 89VO0CMD4F, the compound this issue is built around

• Taraxerol and taraxerone, two more taraxerane triterpenes isolated alongside it

• Myricanol and myricanone, cyclic diarylheptanoids, the compounds with the most modern laboratory data

• Condensed tannins, reported at 3.9 percent of the crude bark and 34.82 percent of the total aqueous extract

• Betulin, ursolic acid, gallic acid, protocatechuic acid

• Bayberry wax on the fruit, esters of lauric, myristic and palmitic acid, melting at 39 to 49 degrees Celsius

Key Note

All four compounds named in the 1974 chemical paper on this plant, myricadiol, myricitrin, taraxerol and taraxerone, come from one two-page report: Paul BD, Rao GS, Kapadia GJ, Journal of Pharmaceutical Sciences, 1974, volume 63, issue 6, pages 958 to 959. Fifty-two years later that paper is still the anchor citation for bayberry's pharmacology in every commercial herbal reference on the market. Nothing has replaced it.

Bayberry is sold today as an immune and throat product, but the chemistry on the label is not the chemistry that should worry a buyer.

Primary Functions & Benefits

Bayberry's documented actions divide cleanly into two piles: what tannins do, which is real and unremarkable, and what the isolated compounds do in cell culture, which is interesting and untested in people.

Astringent action on mucous membranes

Condensed tannins at 3.9 percent of the bark precipitate surface proteins, which tightens inflamed tissue and reduces secretion. This is the basis for the sore throat gargle and the antidiarrheal use, and it is the one traditional application where the chemistry and the claim actually match. It is also the same mechanism as strong black tea, oak bark or witch hazel.

Anti-tau activity of myricanol

Jones JR and colleagues, Journal of Natural Products, 2011, volume 74, pages 38 to 44, screened a Myrica cerifera extract and found it reduced both endogenous and overexpressed tau protein in cells and in murine brain slices. The diarylheptanoid (+)-aR,11S-myricanol was the most effective single component, and myricetin and myricitrin contributed. This is a cell and tissue-slice result with a compound present in the bark at low percentage. It is not a memory claim.

Cytotoxicity of bark triterpenoids

Zhang J and colleagues, Chemistry and Biodiversity, 2016, volume 13, pages 1601 to 1609, isolated 16 compounds from M. cerifera bark. Betulin, ursolic acid and myricanol showed cytotoxicity against HL60 leukemia, A549 lung and SK-BR-3 breast lines with IC50 values of 3.1 to 24.2 micromolar. Myricanol induced apoptosis in HL60 at IC50 5.3 micromolar through caspases 3, 8 and 9.

Antioxidant capacity

In the same 2016 work, myricanol, myricanone, myricitrin, protocatechuic acid and gallic acid scavenged DPPH radicals with IC50 values of 6.9 to 20.5 micromolar. DPPH is a test-tube assay. It predicts nothing about a person.

What is missing

There are zero controlled human trials of Myrica cerifera indexed in Europe PMC. Not a small trial, not an old trial, not a poor one. Zero. Of 230 Europe PMC records mentioning the species, none is a clinical trial of the herb.

Forms & Standardization

Bayberry is one of the least standardized botanicals still in wide retail distribution. No marker compound is assayed by anyone. Across all 211 bayberry-containing labels in DSLD, the words myricadiol, myricitrin and tannin appear zero times.

Cut and sifted root bark

The traditional material. The British Herbal Pharmacopoeia dose is 0.6 to 2.0 g of powdered bark by infusion or decoction three times daily. Boiling water pulls the tannins; alcohol pulls the triterpenes and resin. A water decoction and an alcohol tincture of the same bark are therefore chemically different products, and no label says so.

Capsules of powdered bark

Nature's Sunshine sells 440 mg per capsule at two capsules daily, so 880 mg per day. Swanson Premium sells Full Spectrum Bayberry Root at 400 mg per capsule. TerraVita Premium Collection sells both a 450 mg bark capsule and a 450 mg capsule of 4:1 extract, which is a fourfold concentration difference behind an identical milligram number on the front panel.

Tinctures, 1:5

Herb Pharm's bayberry is a 1:5 hydroalcoholic extract of sustainably wildcrafted root bark, 672 mg of herb equivalent per 0.7 mL squeeze. Herbalist and Alchemist doses at 1.5 mL.

Concentrated liquid extracts

Nature's Answer sells "Bayberry Bark 3,000 mg," which resolves to 3 g of herb equivalent per 3 mL serving, taken 2 to 3 times a day. At the top of that range a user takes 9 g of herb equivalent daily, which is between 4 and 15 times the British Herbal Pharmacopoeia daily range of 1.8 to 6.0 g. Hawaii Pharm and Herbal Terra list 983 mg or 1,156 mg of dry root bark equivalent per mL, up to four times daily.

1:1 fluid extract

The BHP form, 0.6 to 2.0 mL of a 1:1 extract in 45 percent alcohol, three times daily. Rare on the US market.

What no form gives you

Not one product on the US market discloses tannin percentage, triterpene content, extraction solvent strength for the capsules, or which of the two chemically distinct extract types is in the bottle. There is no USP monograph for bayberry root bark. The plant was admitted to the National Formulary in 1916 and dropped roughly 20 years later, and nothing has replaced that standard since.

Food Sources

Bayberry root bark is not a food and has never been eaten as one. There is no dietary intake to compare a supplement against.

The fruit is a different story, and this is where the name causes real trouble. Myrica rubra, Chinese bayberry or yangmei, is a commercially farmed fruit with its own substantial literature: 788 Europe PMC records against 230 for Myrica cerifera. Its edible flesh carries anthocyanins, chiefly cyanidin-3-O-glucoside, plus ferulic, caffeic, sinapic and salicylic acids. The single best human trial in the entire bayberry literature used this fruit, not the bark. Guo H and colleagues, Nutrition, 2014, volume 30, pages 198 to 203, ran a randomized, double-blind, placebo-controlled crossover study in 44 adults aged 18 to 25 with features of non-alcoholic fatty liver disease, giving 250 mL of bayberry juice twice daily for 4 weeks. Plasma TNF-alpha fell significantly (p less than 0.001), interleukin-8 fell (p equals 0.022), and protein carbonyls fell (p equals 0.038). Insulin resistance and anthropometrics did not move.

That trial is real and it is about a juice from a Chinese fruit tree. It says nothing about a capsule of North American root bark, and any marketer who cites it for a M. cerifera product is citing a different species.

The fruit of M. cerifera itself is a waxy drupe, and the wax rather than the pulp is what people historically wanted. Colonial candlemakers boiled the berries and skimmed the floating wax. King's American Dispensatory records that wax as roughly 70 percent palmitin, 8 percent myristin and 4.7 percent lauric acid. It melts at 39 to 49 degrees Celsius, which is why bayberry candles hold their shape in a cool room and slump in a warm one.

Honest answer on food: there is nothing to eat here. If you want the polyphenols, eat berries. If you want the astringent effect, strong tea delivers more tannin per cup than most bayberry capsules deliver per dose.

Who Should Take Bayberry

Very few people, and none for the reason it is currently marketed.

• Someone who wants a short-term astringent gargle for a raw, weeping sore throat and understands they are buying a tannin, the same effect available from black tea, sage or oak bark

• Someone using it topically on a chronic ulcer or as a wash, the historical external use, where the sodium and potassium question does not arise

• Someone treating acute non-infectious diarrhea for two or three days with a decoction, understanding that tannins bind iron and drug molecules along with everything else

Who should not bother

Anyone who bought it for immune support. Of the 211 bayberry-containing labels in DSLD, 42 carry immune language and 26 carry respiratory language, and there is no controlled human evidence behind either claim for this species. The immune positioning is a marketing overlay on a 19th century astringent.

Who Should AVOID or Use Caution

Contraindications

• Pregnancy. Standard herbal references contraindicate bayberry in pregnancy and lactation on the strength of the mineralocorticoid attribution plus the tumorigenicity reports. Despite that, 25 of the 211 bayberry labels in DSLD are Mountain Meadow Herbs "Gentle Birth" products directing use in the last 5 weeks of pregnancy, at a quarter teaspoon two to three times daily. That is the sharpest contradiction in the entire bayberry category.

• Uncontrolled hypertension. If the mineralocorticoid attribution is right, this is exactly the wrong plant. Only one label on the US market, Swanson's Full Spectrum Bayberry Root 400 mg, says so: "Do not take this product if you are pregnant, nursing or have high blood pressure."

• Known bayberry pollen allergy. In a study of 400 consecutive patients evaluated for respiratory allergy in the southern United States, 15 percent had positive skin prick tests to bayberry pollen. In the provocation arm, 12 of 13 skin-test-positive rhinitis patients (92 percent) had positive nasal challenges and 4 of 7 asthmatics (57 percent) had positive bronchial challenges. Bayberry is the fifth most common windborne tree pollen in Tampa, Florida.

Use Caution

• Anyone on a loop or thiazide diuretic, where added sodium retention works directly against the drug

• Anyone on digoxin, where potassium loss raises digitalis toxicity risk at unchanged serum drug levels

• Anyone on systemic corticosteroids, which already push sodium in and potassium out

• Anyone taking oral iron, since tannins at 3.9 percent of the bark bind non-heme iron

• Anyone with existing kidney impairment, edema or heart failure

• Anyone taking the concentrated liquids at label maximums, which reach 9 g of herb equivalent daily

Critical Safety Point

The demographic buying "immune support" botanicals skews older, and older buyers are the most likely to be on an antihypertensive, a diuretic, digoxin or a steroid at the same time. A plant credited with sodium-retaining and potassium-wasting activity, sold with no potassium warning on any of 211 labels, is aimed squarely at the population least able to absorb that effect quietly.

Recommended Dosages

There is no evidence-based dose for bayberry, because there are no dose-finding human studies. Every number below is either a traditional figure or a modern label figure, and none is validated.

Powdered root bark, British Herbal Pharmacopoeia

0.6 to 2.0 g three times daily by infusion or decoction, so 1.8 to 6.0 g per day.

Powdered root bark, King's American Dispensatory (Felter and Lloyd)

20 to 30 grains, roughly 1.3 to 1.9 g. King's also records that doses at the drachm level, about 3.9 g in one go, tend to cause vomiting. That is the "emetic" property of the Thomsonian tradition, and it is dose, not magic.

Liquid extract 1:1 in 45 percent alcohol

0.6 to 2.0 mL three times daily.

Tincture 1:5

Herb Pharm's label works out to 672 mg of herb equivalent per 0.7 mL. Todd Caldecott's clinical range for a 1:5 dry plant tincture is 3 to 60 drops.

Capsules on the current US market

400 mg to 450 mg per capsule, one to two capsules daily. Nature's Sunshine directs 440 mg twice daily with meals.

Concentrated liquids

Nature's Answer directs 1 to 3 mL, 2 to 3 times daily, at 1,000 mg of herb equivalent per mL. Hawaii Pharm and Herbal Terra direct up to 1 mL four times daily at 983 to 1,156 mg per mL. These reach 9 g and 4.6 g of daily herb equivalent respectively, above the top of the traditional range.

Duration

Traditional use is short and symptom-driven, days rather than months. Nothing in the literature supports continuous use, and the mineralocorticoid question is a cumulative-exposure question, which makes long courses the worst version of an unmeasured risk. Treat two weeks as a reasonable ceiling for internal use and stop.

Timing & Administration

Take internal bayberry with food. Tannins on an empty stomach are the most common cause of the nausea people report, and they are also the reason 3.9 percent tannin bark irritates a stomach that strong tea does not.

Separate bayberry from oral iron by at least two hours. Tannins chelate non-heme iron directly, and this interaction is well characterized for tannin-rich plants generally.

For a sore throat, gargle a cooled decoction and spit it out. This puts the tannin where the traditional indication is and keeps the triterpenes out of circulation entirely, which is the only version of bayberry use where the myricadiol question is irrelevant.

Do not take bayberry within a few hours of a dose of any narrow-therapeutic-index oral drug, because tannins bind alkaloids and basic drug molecules in the gut lumen.

Timeline of Effects

Astringent effects: minutes

A tannin gargle tightens mucosa on contact. If a bayberry gargle is going to help a sore throat, you know inside one or two rinses.

Antidiarrheal effects: hours to two days

Traditional practice expected a response within a day or two of decoctions taken three times daily. If stool frequency has not changed after 48 hours, it is not working and the cause is probably not one that astringents touch.

Emetic effects: 20 to 60 minutes

At the drachm-level doses recorded in King's, vomiting is the effect, not a side effect. This was intentional in Thomsonian practice.

Immune or systemic effects: no timeline exists

There is no trial duration to cite because there is no trial. The only 4-week human dosing schedule in the bayberry literature, Guo 2014, used Myrica rubra juice, a different species and a different plant part.

Mineralocorticoid effects, if real: days to weeks

Sodium retention and potassium wasting are cumulative processes. Licorice, the best-characterized botanical with this mechanism, typically takes one to four weeks of regular intake before blood pressure and potassium shift measurably. If myricadiol behaves anything like that class, a two-day course is unlikely to matter and a two-month course might. Nobody has measured it in bayberry, which is precisely the problem.

What counts as a fair trial

For the astringent uses, three days. For anything else, there is no fair trial, because there is no endpoint anyone has validated.

Benefits of Taking Bayberry

Documented in humans

Local astringency on inflamed mucous membranes. That is the complete list, and it rests on tannin chemistry and two centuries of consistent traditional use rather than on trials.

Documented in animals or cells, with the isolated compound rather than the herb

• Myricanol reduced tau protein in cells and murine brain slices (Jones 2011, J Nat Prod 74:38-44)

• Myricanol and myricanone showed cytotoxicity and apoptosis induction in HL60, A549, SK-BR-3, HeLa and PC3 lines at single-digit to low double-digit micromolar concentrations (Zhang 2016, Chem Biodivers 13:1601-1609; Paul A 2013, J Acupunct Meridian Stud 6:188-198)

• Myricitrin at 50 mg/kg reduced serum oxidized LDL by about 25 percent in a mouse atherosclerosis model, matching probucol at a 40-fold lower dose

• Myricanol at 5 mg/kg reduced dexamethasone-induced muscle loss in C57BL/6 mice, and at 25 mg/kg reduced fat accumulation on a high-fat diet

Why none of that is a benefit of the product

Those doses are of purified compounds, given by injection or gavage, in rodents. A 440 mg capsule of whole root bark delivers an unmeasured and undisclosed fraction of any of them. No label states a myricitrin or myricanol content, so no consumer can convert a capsule into a rodent-equivalent dose even approximately.

Potential Negatives & Side Effects

Common at ordinary doses

• Nausea and stomach upset from the tannin load, especially without food

• Astringent dryness and a puckering effect in the mouth

• Constipation with repeated internal use

Dose-dependent

• Vomiting at roughly 3.9 g of powdered bark in a single dose, documented in King's American Dispensatory

• Reduced iron absorption with concurrent oral iron

The one that is not on any label

If the mineralocorticoid attribution is correct, sustained internal use can push sodium and water retention and potassium loss, and the presenting signs would be ankle swelling, a creeping rise in blood pressure, muscle cramps or unexplained weakness. Standard references warn that large doses may cause sodium and water retention and hypertension. Across 211 bayberry labels, the word potassium does not appear once, hypertension does not appear once, diuretic does not appear once, and edema does not appear once.

Allergic and respiratory

Bayberry pollen is a documented aeroallergen with 15 percent skin-test positivity among southern US respiratory allergy patients. Whether bark preparations cross-react is unstudied, but people with known bayberry pollen sensitivity have a reason to be cautious that no bottle mentions.

Deficiency Symptoms

Bayberry is a plant drug with no role in human physiology. The body builds nothing from it, requires none of it, and has no enzyme or pathway that fails in its absence, so there is no deficiency state and no such thing as a low bayberry level.

What bayberry addresses

A symptom, not a shortfall. The astringent effect on an inflamed throat or an irritated gut lining is a surface phenomenon that lasts as long as the tannin is in contact with the tissue. Contrast this with a genuine trace element such as iodine, where an intake below roughly 150 micrograms daily produces measurable thyroid consequences. Nothing similar exists for bayberry at any intake, including zero.

Bottom line

Skipping bayberry entirely for life produces no clinical consequence whatsoever.

Toxicity Symptoms

At high intake

The first thing that happens at high doses is vomiting, at roughly one drachm (3.9 g) of powdered bark, which is a built-in ceiling on accidental overexposure by the traditional route. The concentrated liquid extracts bypass that ceiling: 3 mL of a 1,000 mg/mL product is 3 g of herb equivalent in a teaspoon of fluid, and it goes down without the bulk that triggers the gag response. Sustained high tannin intake also carries a general risk of gastrointestinal irritation and impaired mineral absorption.

Signs to reduce or stop

• New or worsening ankle and lower leg swelling

• A blood pressure reading that has drifted upward without another explanation

• Muscle cramps, weakness or palpitations, which are the classic presentation of falling potassium

• Persistent nausea, vomiting or constipation

• Any new skin or breathing reaction after starting the product

General note

The tumorigenicity question deserves stating plainly and in proportion. Kapadia GJ and colleagues, Journal of the National Cancer Institute, 1976, volume 57, pages 207 to 209, injected 14 extracts and fractions from 6 plants subcutaneously into NIH Black rats. The tannin fractions of Quercus falcata var. pagodaefolia, Diospyros virginiana and Camellia sinensis produced malignant fibrous histiocytomas at the injection site in 66 percent or more of treated animals, and tannin fractions from 3 further plants plus the total aqueous extracts of 5 of the 6 were also tumorigenic. A companion 1978 paper in the same journal, volume 60, pages 683 to 686, gave 72 weekly subcutaneous injections of 12 herbs, with Areca catechu tannin producing tumors in 100 percent of animals. Standard herbal references attribute a bayberry arm to this work and report tannin at 3.9 percent of the bark and 34.82 percent of the total aqueous extract, with tumors from both the tannin and tannin-free fractions, and they note that later work did not reproduce the finding. Two things are true at once: repeated subcutaneous injection of a concentrated tannin fraction is not a model of drinking a decoction, and Camellia sinensis is tea, which several billion people drink daily without a matching cancer signal. The finding is a reason to avoid long-term high-dose internal use of a tannin-heavy bark. It is not a reason to panic about a gargle.

How Bayberry Works

Bayberry works through at least three separate mechanisms, and they do not act on the same timescale or through the same tissue.

Tannins act physically, at the surface

Condensed tannins are polyphenols with many hydroxyl groups that cross-link and precipitate proteins in mucus and in the outermost cell layer. That coagulated layer reduces secretion, tightens the tissue and forms a temporary barrier. It is a contact effect. Nothing needs to be absorbed, and once the tannin is washed away the effect ends.

Myricitrin has to be cleaved before it can act systemically

Myricitrin is myricetin carrying a rhamnose sugar. Flavonoid rhamnosides are poorly taken up intact by small-intestinal transporters, so the systemic exposure to the aglycone depends on gut bacteria releasing it further down. This means the rodent studies that dosed purified myricitrin at 50 mg/kg do not map cleanly onto a person swallowing an undisclosed quantity inside 440 mg of bark.

Myricadiol acts like a steroid, if it acts at all

Taraxerane triterpenes share the fused four-ring skeleton of the corticosteroids. Mineralocorticoid activity means binding or otherwise engaging the mineralocorticoid receptor in the distal nephron, which drives sodium reabsorption through epithelial sodium channels and drives potassium out into the urine in exchange. That is the same endpoint licorice reaches by a different route, and it is a slow, cumulative, whole-body effect rather than a local one. Whether myricadiol actually does this at any achievable oral dose is the open question at the center of this issue.

Synergistic Supplements

Nothing in the literature demonstrates a bayberry combination that outperforms bayberry alone in a human study, because no human study of bayberry exists. What follows are traditional pairings and their honest rationale.

• Ginger (Zingiber officinale) and cayenne (Capsicum annuum), the Thomsonian "composition powder" pairing, both of which appear alongside bayberry in current DSLD blends. The rationale was warming and circulation, not evidence.

• Marshmallow root (Althaea officinalis) or slippery elm, demulcents that offset the drying feel of a tannin gargle. Both appear in current bayberry blends.

• Sage (Salvia officinalis) for a throat gargle, another tannin-bearing astringent with actual gargle trial data behind it.

• Vitamin C and zinc if the goal is genuinely respiratory support, since both have human trial data and bayberry does not.

A pairing to avoid

Do not combine bayberry with licorice root (Glycyrrhiza glabra), which appears in 3 bayberry-containing DSLD blends. Licorice has unambiguous, well-quantified mineralocorticoid-like effects through glycyrrhizin's inhibition of 11-beta-hydroxysteroid dehydrogenase type 2. Stacking a proven sodium-retaining, potassium-wasting botanical with a suspected one is the exact combination nobody has studied and nobody should volunteer for.

Interactions & What NOT to Take

Named drugs where the mineralocorticoid question matters most

• Furosemide, bumetanide, torsemide. Loop diuretics already waste potassium. Adding a suspected potassium-waster compounds it.

• Hydrochlorothiazide, chlorthalidone, indapamide. Same logic, plus the sodium retention works against the antihypertensive effect.

• Digoxin. Falling potassium increases myocardial sensitivity to digoxin without changing the serum digoxin level, so the standard monitoring will not catch it.

• Lisinopril, losartan, amlodipine and every other antihypertensive. Sodium and water retention blunts them.

• Prednisone, hydrocortisone, fludrocortisone. Additive sodium retention and potassium loss.

• Spironolactone and eplerenone. These are mineralocorticoid receptor antagonists. A mineralocorticoid agonist is their pharmacological opposite.

Tannin-driven interactions, which are certain rather than suspected

• Ferrous sulfate, ferrous gluconate and every oral iron salt. Separate by two hours minimum.

• Alkaloid drugs and other basic molecules, which tannins bind in the gut lumen. Separate dosing.

• Levothyroxine and other narrow-therapeutic-index oral drugs, on general absorption grounds.

What not to take alongside it

• Licorice, as above

• Any other high-tannin botanical taken internally at dose, including oak bark, witch hazel taken internally, or heavy black tea intake, since the tannin load stacks

• Potassium-wasting stimulant laxatives such as senna or cascara over long periods

Quality, Testing & Adulteration

This is the section where bayberry looks worst, and the numbers are unusually clean.

No standard exists

There is no USP monograph and no NSF or ConsumerLab certification program for bayberry root bark. The plant was in the National Formulary starting in 1916 and was dropped about two decades later. Since then no compendial identity or purity standard has replaced it, so a certificate of analysis for bayberry has nothing to test against beyond generic heavy metals, microbials and a botanical identity check.

Nobody assays a marker

Across all 211 bayberry-containing labels in DSLD, checked August 2026, the words myricadiol, myricitrin and tannin appear zero times. Seventeen labels use the word "standardized," and in every case it refers to a different ingredient in the same blend.

Root bark versus stem bark versus leaf

Traditional practice specifies root bark. Most labels say "bark" or "root bark," but "Bayberry" with no plant part appears on multiple products, including Nature's Sunshine's 440 mg capsule, which lists the ingredient simply as "Bayberry." Root bark, stem bark and leaf differ in triterpene and tannin profile, and there is no way to check which one is in an unqualified capsule.

Species substitution risk

Because Myrica rubra is a large commercial fruit crop with 788 Europe PMC records to M. cerifera's 230, and because both are sold in English as "bayberry," the naming overlap is a live substitution and mis-citation risk. Myrica pensylvanica, the northern species, carries the same common name in the northeastern US and has 43 Europe PMC records to its name. A supplier writing "bayberry extract" without a binomial has told you nothing, and a marketer citing a Laurus nobilis bay leaf study for a bayberry capsule has crossed two plant orders. Insist on a binomial and a plant part.

What a buyer can actually verify

• A binomial on the label, either Myrica cerifera or Morella cerifera

• An explicit plant part, root bark

• An extract ratio for liquids, such as Herb Pharm's 1:5, and a stated menstruum strength

• A cGMP statement referencing 21 CFR part 111, which several bayberry marketers do print

• An amount. In DSLD, 153 of 211 bayberry-containing labels, 73 percent, place bayberry inside a proprietary blend or otherwise do not disclose how much is in the product.

Special Considerations

Pregnancy and lactation

Reference texts contraindicate bayberry in both, and 25 DSLD labels sell it for the last five weeks of pregnancy. Nothing has reconciled these two positions, and no data exist to settle it.

Older adults on cardiovascular medication

This is the population the product's marketing reaches and the population the pharmacology should exclude. Immune language appears on 42 of the 211 labels.

People with kidney disease or heart failure

Sodium and water retention is the specific thing these patients are managing. A suspected mineralocorticoid with no dose data belongs nowhere near them.

Children

Two of the bayberry-containing labels are targeted at users under 18 by directing "consult a physician before giving to children under 18," which is a disclaimer, not a dose. There is no pediatric data.

Surgery

Discontinue two weeks before scheduled surgery, on the grounds that electrolyte and blood pressure effects, if real, are the exact variables anesthesia depends on.

Allergy history

Bayberry pollen sensitization runs at 15 percent among southern US respiratory allergy patients, and 92 percent of skin-test-positive rhinitis patients reacted to nasal challenge in the provocation study. Anyone in that group should treat bark preparations as unstudied rather than safe.

Research Status & Evidence Quality

Strong Evidence For

Nothing. There is no category of bayberry use supported by strong human evidence, because there are no controlled human trials of Myrica cerifera at all.

Moderate Evidence For

• Local astringent action of the bark's tannins on mucous membranes. The mechanism is settled chemistry and the traditional record is consistent across two centuries, even though no modern trial has measured it.

• Bayberry pollen as a genuine aeroallergen, supported by skin prick testing in 400 consecutive patients and by nasal and bronchial provocation challenges in 45 subjects.

Emerging / Preliminary Evidence For

• Myricanol as an anti-tau scaffold, on cell and murine brain-slice data from 2011

• Myricanol and myricanone cytotoxicity in HL60, A549, SK-BR-3, HeLa and PC3 lines at 3.1 to 24.2 micromolar

• Myricitrin cardiovascular and anti-inflammatory effects in rodents at 40 micromolar in vitro and 50 mg/kg in vivo

• Anti-inflammatory activity of 3-acetylmyricadiol in LPS-stimulated RAW 264.7 macrophages, reported in 2022, which is the only modern pharmacology on any myricadiol derivative

Research Limitations

The myricadiol mineralocorticoid claim is the clearest example of a citation that has outlived its evidence. It originates in a two-page isolation note from 1974 with no indexed abstract, and it has been copied forward into reference works, retail monographs and herbalist training material ever since. As of August 2026, Europe PMC holds 32 records that mention myricadiol in any context, none pairing it with the term mineralocorticoid, and exactly one record pairs Myrica cerifera with mineralocorticoid, a veterinary herbal textbook chapter rather than a study. There is no published receptor binding assay, no adrenalectomized-rat bioassay, no sodium or potassium excretion measurement and no human data. Nobody has ever shown the effect does not happen either. That combination, a plausible steroid-skeleton mechanism, a fifty-year-old attribution, and zero measurements in either direction, is the worst possible state for a compound sold to people on diuretics.

The tumorigenicity literature has the same shape: two 1970s subcutaneous injection studies in rats, a route nobody uses, results that later work reportedly did not reproduce, and a claim that has been repeated as settled ever since.

Summary & Key Takeaways

Bayberry is a 19th century astringent that acquired a 21st century immune-support label without acquiring a single controlled human trial. Samuel Thomson (1769 to 1843) built it into his botanic system as remedy No. 3, the "canker" agent, and wrote that it was the best remedy for canker he had ever found. King's American Dispensatory recorded the dose that makes people vomit, 20 to 30 grains as an astringent and a drachm as an emetic. The National Formulary carried the root bark from 1916 for roughly two decades and then dropped it. In 1974 three chemists at Howard University pulled four compounds out of the root bark in a two-page note, and one line in that note about myricadiol became the safety warning that every reference book has repeated ever since without anyone going back to measure it.

Bottom Line

The astringent use is real, cheap, and available from a dozen better-characterized plants. The immune positioning has nothing behind it. And the one pharmacological property that would genuinely change who should take this plant, a mineralocorticoid effect that would raise sodium retention and drive potassium out, appears on exactly one of 211 US labels as a blood pressure warning and on none of them as a potassium warning.

Key Safety Points

• If you take a diuretic, an antihypertensive, digoxin, spironolactone or a corticosteroid, skip bayberry entirely. The interaction is unproven, unmeasured, and points in only one direction.

• Do not use it internally during pregnancy, whatever the "Gentle Birth" labels say.

• Keep internal courses short. The mineralocorticoid question and the tannin question are both cumulative-exposure questions.

• Buy only a product with a binomial, a plant part and a disclosed amount. 73 percent of bayberry labels fail that test.

• A gargle you spit out avoids the entire systemic question.

Special Note

Bayberry demonstrates a failure mode worth carrying to every other shelf: a safety claim can be repeated for fifty years and still have no measurement under it. When a reference book tells you a botanical has hormone-like activity, ask which paper, what model, what dose, and what was measured. If the trail ends at a two-page isolation note from 1974 with no abstract, you have not found evidence. You have found a sentence that nobody checked, attached to a plant that nobody warns about, sold to the people it would hurt.